Biocon Announcements
Biocon Limited has informed the Exchange regarding a press release dated October 23, 2025, titled "Biocon Biologics Receives Health Canada Approval for Yesintek and Yesintek...
23 Oct, 2025 | 08:46am • Source: NSE
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
13 Oct, 2025 | 06:29pm • Source: BSE
Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)
09 Oct, 2025 | 04:48pm • Source: BSE
Submission of copy of Biocon Limited Employees Welfare Trust Amendment Deed
09 Oct, 2025 | 01:19pm • Source: BSE
Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve...
06 Oct, 2025 | 07:54pm • Source: BSE
The Board of Directors of the Company at its meeting held today has approved the early full redemption of 1,07,000 unlisted, secured, rated, redeemable, Non-Convertible...
01 Oct, 2025 | 08:09pm • Source: BSE
Press Release
01 Oct, 2025 | 08:59am • Source: BSE
Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/10/2025 ,inter alia, to consider and approve...
28 Sep, 2025 | 11:27pm • Source: BSE
Announcement under Regulation 30 - Receipt of show cause notice
25 Sep, 2025 | 05:15pm • Source: BSE
Intimation of record date for buy back of listed Commercial Paper issued by the Company
17 Sep, 2025 | 07:05pm • Source: BSE
Press Release
17 Sep, 2025 | 04:16pm • Source: BSE
Press Release
12 Sep, 2025 | 05:32pm • Source: BSE
Biocon Limited has informed the Exchange regarding a press release dated September 10, 2025, titled "Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey
11 Sep, 2025 | 08:51am • Source: NSE
Email communication to shareholders under 100 Days Campaign - ''Saksham Niveshak''
10 Sep, 2025 | 08:14pm • Source: BSE
Outcome of Board Meeting - Change in Company Secretary and Compliance Officer
09 Sep, 2025 | 08:12pm • Source: BSE